Measles is a rash illness resulting from infection with the measles virus. It can affect people of all ages but infants less than one year of age and those who are immunocompromised are at increased risk of complications and death. It's one of the most communicable diseases with one case having the potential to infect another 12 to 18 individuals through airborne transmission and respiratory droplets in susceptible populations.

MMR is the combined vaccine that protects against measles, mumps and rubella and is the most effective strategy for preventing the transmission of measles.

For more information on measles, visit the NHS Choices website.


For all infection prevention and control guidance visit the A-Z ​pathogens section of the National Infection and Prevention Control Manual.


Data and surveillance

Before vaccination, measles was a very common childhood disease in Scotland and deaths attributable to measles were substantial. Following the introduction of measles vaccine in 1968 and the subsequent introduction of the MMR vaccine in 1988, the incidence of the disease has decreased dramatically. However, as Figure 1 shows, outbreaks still occur in under immunised populations.

Figure 1: Number of laboratory-confirmed cases of measles in Scotland by year, 1988 to 2020 (to week 26)

Figure 1 is a line chart showing the number of laboratory-confirmed cases of measles reported in Scotland by year from 1988 to 30 June 2020. The figure shows a sharp increase in the number of measles cases in 1994, when 536 cases were reported. The number of cases decreased to 23 in 1995 and has generally remained low since, with the exception of 2008 (when 53 cases were reported) and 2013 (when 51 cases were reported). There were no cases reported in 2015, 26 cases reported in 2016, 5 cases reported in 2017, and 2 cases reported in 2018. 18 cases were reported in 2020 and no cases have been reported to date in 2020. The graph is also annotated with relevant time points in measles vaccination, with the MMR vaccine introduced in 1988, the measles/rubella campaign initiated in 1994, and the second dose of MMR added to the vaccine schedule in 1996.

Surveillance update for April to June 2020

As shown in Figure 2, the annual number of laboratory-confirmed measles cases has been variable; with no cases in 2015; 26 in 2016; five laboratory-confirmed cases in 2017, all of which were imported or linked to an imported case within or outwith the UK and two imported cases reported in 2018.

In 2019, 18 laboratory confirmed cases of measles were reported. Of these, one case was acquired elsewhere within the UK, outwith Scotland; from which two further cases were subsequently identified. Seven cases were imported from outwith the UK, and resulted in two import-related cases in Scotland. The remaining six laboratory confirmed cases of measles in Scotland were of unknown origin. However preliminary typing indicates the majority of these cases to be of the strain demonstrated for elsewhere in the UK and Europe. 

No cases of measles have been reported in Scotland in the first quarter of 2020.

In highly vaccinated populations such as Scotland, rarely, individuals who have received two doses of MMR vaccine can develop symptoms following exposure to a measles case, but symptoms are usually attenuated and individuals are unlikely to be as infectious. No sustained further transmission occurred in Scotland, highlighting the success of the MMR vaccination programme and the importance of maintaining high vaccine uptake in Scotland.

Figure 2: Number of laboratory-confirmed cases of measles in Scotland by month and year, 2015 to 2020 (to week 26)

Figure 2 is a bar chart showing the number of laboratory-confirmed cases of measles reported in Scotland by month and year between 2015 to June 2020. The graph shows that the number of measles cases fluctuates each year. In 2016, measles cases were reported throughout the year, with a peak in October. In 2017 and 2018, cases were reported during the spring and summer months. In 2019, cases have were reported in February, in May through to August and October. No cases have been reported in 2020.

Measles outbreaks occurred across Europe throughout 2018 and have continued into 2019. Between March 2019 and February 2020, 11,576 cases of measles were reported to the European Centre for Disease Prevention and Control. The EU/EEA countries with the most cases reported in between March 2019 and February 2020 are:

  • France with 2,466 cases (21% of all cases)
  • Romania with 1,542 cases (13% of all cases)
  • Italy with 1,353 (12% of all cases)
  • Bulgaria with 1,343 cases (12% of all cases)
  • Poland with 1,032 cases (9% of all cases)

Increased measles activity in Europe and globally poses a threat to international travellers and Scotland will continue to face an elevated risk of imported cases from other counties and other regions of the UK.

Age distribution of cases

In 2020 to date, no cases of measles have been reported.

The median age of the 18 laboratory-confirmed cases measles cases reported in Scotland in 2019 is 24 years. This compares to the median age of cases in 2016 (22 years) and 2017 (27 years). The median age of the two measles cases in Scotland in 2018 is not reported due to the potential for deductive disclosure. The age distribution of measles cases has varied over recent years but the majority of cases are observed in children and young adults.



Vaccine Uptake Statistics

Vaccine uptake statistics are published by Public Health Scotland Data and Intelligence.